NCT03504410 2023-02-08Efficacy/Safety of CPI-613 in Combination With HD Cyt. and Mito. vs HD Cyt. and Mito. in Older Patients With R/R AMLCornerstone PharmaceuticalsPhase 3 Terminated200 enrolled 9 charts
NCT03504423 2023-01-03Study Evaluating Efficacy and Safety of FFX Versus Combination of CPI-613 With mFFX in Patients With Metastatic Adenocarcinoma of the PancreasCornerstone PharmaceuticalsPhase 3 Completed528 enrolled 11 charts